Description
Selpercatinib, sold under the brand name Retevmo among others, is a medication for the treatment of cancers in people whose tumors have an alteration (mutation or fusion) in a specific gene (RET which is short for “rearranged during transfection”).
Retevmo is an oral targeted therapy for the treatment of NSCLC, medullary thyroid cancer, and other types of thyroid cancers in individuals whose tumors have an alteration (mutation or fusion) in a specific gene (RET or rearranged during transfection).
Get Access To RETEVMO (selpercatinib) capsules In India
Brand Name “RETEVMO (selpercatinib) capsules” or Generic Name “selpercatinib capsules” can be imported for personal use under “Named Patient Program” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at support@southdelhipharma.net, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.